Dipyrone-induced oligohydramnios and ductus arteriosus restriction.
Weintraub
Amir
A
Department of Obstetrics and Gynecology, Hadassah University Hospital and Hebrew University-Hadassah Medical School, Jerusalem, Israel.
Mankuta
David
D
D000082:Acetaminophen / Q000008:administration & dosage; D000328:Adult; D018712:Analgesics, Non-Narcotic / Q000008:administration & dosage; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D001437:Bacteriuria / Q000188:drug therapy / Q000382:microbiology; D002444:Cefuroxime / Q000008:administration & dosage; D003251:Constriction, Pathologic / Q000139:chemically induced / Q000175:diagnosis; D004177:Dipyrone / Q000009:adverse effects*; D004373:Ductus Arteriosus / Q000000981:diagnostic imaging / Q000187:drug effects* / Q000503:physiopathology*; D005260:Female; D006801:Humans; D016104:Oligohydramnios / Q000139:chemically induced* / Q000175:diagnosis; D011247:Pregnancy; D011248:Pregnancy Complications / Q000139:chemically induced* / Q000175:diagnosis; D014463:Ultrasonography
D018712:Analgesics, Non-Narcotic; D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000082:Acetaminophen; D004177:Dipyrone; D002444:Cefuroxime